These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19172139)

  • 1. Implantable cardioverter defibrillators.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):6-7. PubMed ID: 19172139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Automated implantable cardioverter/defibrillators. Indications for implantation and clinical results].
    Ulbricht LJ; Emmerich K; Probst H; Krakau I; Gülker H
    Z Kardiol; 1995; 84 Suppl 2():127-36. PubMed ID: 7571776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
    Sweeney MO
    Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
    [No Abstract]   [Full Text] [Related]  

  • 4. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 5. The implantable cardiac defibrillator.
    Kamalvand K; Gill JS
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):37-41. PubMed ID: 8646390
    [No Abstract]   [Full Text] [Related]  

  • 6. A prophylactic ICD? Who are the patients? What is the device?
    Nisam S
    Europace; 2001 Oct; 3(4):269-74. PubMed ID: 11678383
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the "emergency room in the chest".
    Campbell S
    Health Care Strateg Manage; 1998 Mar; 16(3):17. PubMed ID: 10177104
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable defibrillators and sudden cardiac death.
    Josephson M; Wellens HJ
    Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract]   [Full Text] [Related]  

  • 10. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 11. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators].
    Daubert JC
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):93-4. PubMed ID: 16555690
    [No Abstract]   [Full Text] [Related]  

  • 13. Chapter 1. Summary of the CCS Consensus Conference on prevention of sudden death from cardiac arrhythmia.
    Connolly SJ; Talajic M
    Can J Cardiol; 2000 Oct; 16(10):1298-302. PubMed ID: 11064304
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrillation in the Brugada syndrome.
    Kadish A
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):267-8. PubMed ID: 15817084
    [No Abstract]   [Full Text] [Related]  

  • 16. Hearts 'too bad' to survive 'too good' to die.
    Fontaine G; Fornes P; Fontaliran F
    Eur Heart J; 2000 Aug; 21(15):1209-11. PubMed ID: 10924308
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study".
    Boriani G; Diemberger I; Grigioni F
    Circulation; 2008 Sep; 118(14):e515; author reply e516. PubMed ID: 18824650
    [No Abstract]   [Full Text] [Related]  

  • 19. Chapter 2. Guidelines and recommendations for ICD therapy.
    Noorani HZ
    Can J Cardiol; 2000 Oct; 16(10):1303-6. PubMed ID: 11064305
    [No Abstract]   [Full Text] [Related]  

  • 20. Defibrillator implantation without induction of ventricular fibrillation: good enough?
    Curtis AB
    Circulation; 2007 May; 115(18):2370-2. PubMed ID: 17485589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.